Skip Navigation

The Center

  • Susan F. Smith leadership team

    The Susan F. Smith Center for Women's Cancers Leadership Team
    (left to right) Doctors Judy E. Garber, Eric P. Winer, Ursula Matulonis, and Alan D. D'Andrea

  • The Susan F. Smith Center for Women's Cancers at Dana-Farber unites many of the world's leading experts in breast cancer, gynecologic cancer, and genetics under one common goal: to give patients the latest, most advanced care, including innovative therapies that are often available only through clinical trials. Bringing patient care and research in women's cancers under a single umbrella creates a natural alliance for better care and smarter science.

    A place of hope and action, the Susan F. Smith Center bridges compassionate care with world-class basic and clinical research. We offer a full spectrum of services that nourish body, mind, and spirit. From the moment a patient arrives for her first appointment to the day her treatment ends, we surround her with a circle of support.

    Leadership team

    Dr. Alan D’Andrea is director of the Susan F. Smith Center for Women’s Cancers, director of the Center for DNA Damage and Repair at Dana-Farber, and the Alvan T. and Viola D. Fuller American Cancer Society Professor of Radiation Oncology at Harvard Medical School. He leads a Stand Up To Cancer Dream Team focused on ovarian cancer, specifically therapies involved in DNA repair, including PARP inhibitors.

    Additional biographical information

    Dr. Eric Winer is director of the Breast Oncology Program. He is also Chief Strategy Officer and Chief of the Division of Women's Cancers at Dana-Farber, the Thompson Senior Investigator in Breast Cancer Research, and a Professor of Medicine at Harvard Medical School. Dr. Winer has conducted numerous clinical trials during his career spanning virtually all aspects of breast cancer. Currently, he is the principal investigator of the Dana-Farber/Harvard Cancer Center NCI SPORE (National Cancer Institute Specialized Program of Research Excellence) in breast cancer. His research group focuses on improving care through the development of new treatment approaches.

    Additional Biographical Information
    Full Treatment Team

    Dr. Ursula Matulonis is director of the Gynecologic Oncology Program and a Professor of Medicine at Harvard Medical School. Her research focuses on targeted therapies for gynecologic malignancies, with a specific interest in the genetic changes in ovarian cancer and how that can lead to targeted drug selection. Dr. Matulonis is principal investigator of several clinical trials and translational studies for ovarian cancer.

    Additional Biographical Information
    Full Treatment Team

    Dr. Judy Garber is director of the Center for Cancer Genetics and Prevention and a Professor of Medicine at Harvard Medical School. She has led studies of epidemiology, cancer surveillance, cancer genetics service delivery, and chemoprevention in hereditary cancers. Dr. Garber’s recent research has evaluated novel agents targeting DNA repair defects in treatment and prevention of triple-negative or basal-like breast cancer, the most common form of cancer in women with germline BRCA1 mutations.

    Additional Biographical Information
    Full Treatment Team

    History

    The Susan F. Smith Center for Women's Cancers began as an idea to unite the clinical and research strengths of the breast and gynecologic cancer programs. This notion of a center dedicated to studying and treating all women's cancers captured Dana-Farber Trustee Susan F. Smith's imagination. Her determination to make the center a reality — along with the strong support of many other individuals and organizations — has been a steady force behind its growth.

    Today, we are pushing the frontier of research for women's cancers by developing innovative therapies and setting cancer care standards for other physicians across the country and around the world.

    Strengthening collaborations

    The Susan F. Smith Center was designed to increase opportunities for scientific collaboration. Physicians and scientists don’t have to travel far to meet: an enclosed bridge connects clinical care with corresponding research facilities in the Richard A. and Susan F. Smith Research Laboratories next door. The proximity promotes translational research that converts scientific advances into new treatments.

  • Susan F. Smith

    Remembering Susan F. Smith

    Susan F. Smith is remembered as a tireless advocate for women's cancer research and care.

    Executive Council members

    Women's Executive Council

    The Executive Council of the Susan F. Smith Center for Women's Cancers at Dana-Farber is a forum for women business and community leaders who are committed to helping find cures for women's cancers.

    Lauren Czapla, NP, warmly embraces young adult patient Alexis Flanagan

    Support Research and Treatment at the Susan F. Smith Center

    Your gift to the Susan F. Smith Center for Women’s Cancers provides hope to women around the world who are facing a cancer diagnosis, or who are survivors of cancer.